IntelGenx Technologies Corp.
OTC: IGXT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Tommy Kenny
- Employees
- 48
- Headquarters
- Montreal, Canada
- IPO year
- 2007
- Market cap
- $29.7M
- Website
- https://www.intelgenx.com
Loading IGXT…
Loading profile data…Frequently asked questions about IGXT
What does IntelGenx Technologies Corp. (IGXT) do?
IntelGenx Technologies Corp. operates as a specialized drug delivery firm, concentrating on the creation and production of innovative oral thin film products for the pharmaceutical industry. Their current portfolio features several oral film formulations: INT0008/2008, a Rizatriptan product addressing migraine headaches; INT0046/2018, intended f...
Where does IGXT trade?
IntelGenx Technologies Corp. (IGXT) trades on the Other OTC.
What sector is IGXT in?
IntelGenx Technologies Corp. (IGXT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of IntelGenx Technologies Corp.?
Tommy Kenny is the chief executive officer of IntelGenx Technologies Corp. (IGXT).
Where is IntelGenx Technologies Corp. headquartered?
IntelGenx Technologies Corp. is headquartered in Canada.
Does IGXT pay a dividend?
IntelGenx Technologies Corp. (IGXT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IGXT go public?
IntelGenx Technologies Corp. (IGXT) completed its initial public offering in 2007.